The University of Texas, Houston Chooses GenoLogics to Provide a Cross-Science Research Informatics Solution for Multiple Labs
Victoria, BC, Canada ─ July 2, 2008 ─ GenoLogics, the leader in translational research informatics solutions for life sciences, today announced that The University of Texas, Health Sciences Center – Houston (UTHSC-H) has selected GenoLogics to provide an informatics solution to support its clinical and translational research initiative.
The University of Texas Health Sciences Center – Houston is partnering with The University of Texas M. D. Anderson Cancer Center and the Memorial Hermann Hospital System to conduct research under the newly formed Center for Clinical and Translational Sciences. The Center, which was created to accelerate the translation of basic research into clinical applications, is funded by a Clinical and Translational Science Award from the National Institute of Health.
“We are developing new and creative ways to accelerate the delivery of discoveries from our laboratories to our patients,” said Dr. Peter Davies, Executive Vice President for Research (UTHSC-H). “We recognize that moving discoveries from the bench to the bedside is enabled by putting in place sophisticated informatics systems that allow us to work with and keep track of the enormous amounts of clinically relevant research data that can be generated by our research scientists. “
Enabling a translational research initiative involves many challenges, including the management of the transfer of data between clinical and research domains, as well as the sharing of data between multiple labs and institutions. With seamless data integration on a common informatics platform, the GenoLogics translational research informatics solution can bring disparate data together and support the complex workflows of organizations conducting translational research outcomes.
“We chose the GenoLogics’ data management system because it can effectively integrate our omics data and healthcare information into a common platform across multiple facilities and collaborators,” said Dr. Davies. “The GenoLogics system will improve the flow of information between multiple core laboratories and the clinic thereby allowing our investigators to apply the most sophisticated research technologies to the understanding of complex human diseases.”
“Our translational research informatics solution is ideal for leading groups such as The University of Texas, Houston who are working with multiple collaborators and trying to connect data from across different systems,” said Michael Ball, CEO of GenoLogics. “Our highly configurable platform is flexible enough to adapt to each client’s unique requirements and our team excels at collaborating with clients to design a solution that meets their needs.”
GenoLogics provides research organizations with informatics solutions for both the biomedical and discovery areas with two complementary product lines – our new integrated suite for Biomedical Informatics and our existing product suite for Research Informatics. Together they provide a holistic solution that enables any institute or research center to become more efficient, share information and accelerate their research.
About GenoLogics
GenoLogics provides enterprise level informatics solutions to the life sciences market that spans both the discovery and biomedical research domains. Our science purposed modules for discovery research are complemented by a highly configurable, integrating lab informatics platform that is scalable to service many labs and sciences across an organization. Our biomedical informatics product suite allows labs to track and manage their biospecimen and clinical annotations data, while aggregating results with our research informatics system for a holistic solution. For more information, please visit www.genologics.com .
